BIOF has been successfully added into Your Stock Email Alerts list.
You can manage your stock email alerts here.
BIOF has been removed from your Stock Email Alerts list.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash to Debt | 0.052 |
BIOF's Cash to Debt is ranked lower than
82% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 1.31 vs. BIOF: 0.052 ) |
BIOF'
s 10-Year Cash to Debt Range
Min: 0.02 Max: 0.08 Current: 0.05 |
| Equity to Asset | 0.225 |
BIOF's Equity to Asset is ranked lower than
81% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 0.50 vs. BIOF: 0.225 ) |
BIOF'
s 10-Year Equity to Asset Range
Min: 0.16 Max: 0.32 Current: 0.23 |
| F-Score: 3 |
|
| Z-Score: -0.35 |
|
| M-Score: -3.55 |
|
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating margin (%) | -8.70 |
BIOF's Operating margin (%) is ranked lower than
83% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 5.30 vs. BIOF: -8.70 ) |
BIOF'
s 10-Year Operating margin (%) Range
Min: -21 Max: -1.2 Current: -8.7 |
| Net-margin (%) | -8.6 |
BIOF's Net-margin (%) is ranked lower than
83% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 3.50 vs. BIOF: -8.6 ) |
BIOF'
s 10-Year Net-margin (%) Range
Min: -22.7 Max: -1.3 Current: -8.6 |
| ROE (%) | -70.9 |
BIOF's ROE (%) is ranked lower than
88% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 6.00 vs. BIOF: -70.9 ) |
BIOF'
s 10-Year ROE (%) Range
Min: -70.9 Max: -9.2 Current: -70.9 |
| ROA (%) | -15.9 |
BIOF's ROA (%) is ranked lower than
87% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 3.20 vs. BIOF: -15.9 ) |
BIOF'
s 10-Year ROA (%) Range
Min: -15.9 Max: -2.9 Current: -15.9 |
| ROC (Joel Greenblatt) (%) | -18.20 |
BIOF's ROC (Joel Greenblatt) (%) is ranked lower than
85% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 9.20 vs. BIOF: -18.20 ) |
BIOF'
s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -18.2 Max: -0.1 Current: -18.2 |
| Daniel Loeb 1,008,432 sh (+261.52%) | David Einhorn 1,358,437 sh (unchged) |
| David Einhorn 1,427,819 sh (+5.11%) Daniel Loeb 1,043,123 sh (+3.44%) |
| David Einhorn 1,427,819 sh (unchged) Daniel Loeb 1,043,123 sh (unchged) |
| David Einhorn 1,427,819 sh (unchged) Daniel Loeb 1,043,123 sh (unchged) |
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| Daniel Loeb | 2012-06-30 | Add 261.52% | 0.08% | $3.72 - $13.4 | $ 4.78 | -40% | 1008432 | |
| George Soros | 2011-06-30 | Sold Out | $8.25 - $16.3 | $ 4.78 | -61% | 0 | ||
| George Soros | 2011-03-31 | Reduce -48.18% | $16 - $34.8 | $ 4.78 | -78% | 23576 | ||
| George Soros | 2010-09-30 | Reduce -26.73% | $22 - $44.4 | $ 4.78 | -83% | 48800 | ||
| George Soros | 2010-06-30 | Add 23.79% | $27.2 - $62.8 | $ 4.78 | -89% | 66600 | ||
| George Soros | 2010-03-31 | Add 57.4% | $54.2 - $82.6 | $ 4.78 | -92% | 53800 |
More recent guru trades are included for Premium Members only!!
| vs
industry |
vs
history |
||
|---|---|---|---|
| P/B | 0.53 |
BIOF's P/B is ranked higher than
94% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 1.69 vs. BIOF: 0.53 ) |
BIOF'
s 10-Year P/B Range
Min: 0.08 Max: 1.34 Current: 0.53 |
| P/S | 0.06 |
BIOF's P/S is ranked lower than
99% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 0.80 vs. BIOF: 0.06 ) |
BIOF'
s 10-Year P/S Range
Min: 0.02 Max: 0.21 Current: 0.06 |
| PFCF | 20.78 |
BIOF's PFCF is ranked higher than
98% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 17.30 vs. BIOF: 20.78 ) |
BIOF'
s 10-Year PFCF Range
Min: 0.97 Max: 56.08 Current: 20.78 |
| EV-to-EBIT | -5.45 |
BIOF's EV-to-EBIT is ranked higher than
78% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 14.32 vs. BIOF: -5.45 ) |
BIOF'
s 10-Year EV-to-EBIT Range
Min: 27.2 Max: 308.7 Current: -5.45 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price/Tangible Book | 0.5 |
BIOF's Price/Tangible Book is ranked higher than
54% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 2.30 vs. BIOF: 0.5 ) |
BIOF'
s 10-Year Price/Tangible Book Range
Min: 0.1 Max: 0.9 Current: 0.5 |
| Price/Median PS Value | 1.1 |
BIOF's Price/Median PS Value is ranked higher than
80% of the 565 Companies in the Global Specialty Chemicals industry. ( Industry Median: 0.70 vs. BIOF: 1.1 ) |
BIOF'
s 10-Year Price/Median PS Value Range
Min: 0.7 Max: 2.6 Current: 1.1 |
| Industry: | Specialty Chemicals |
|---|---|
| Compare: | NEU, SCL, VAL, POL, CYT |